Ligand-Induced Activation of GPR110 (ADGRF1) to Improve Visual Function Impaired by Optic Nerve Injury

Int J Mol Sci. 2023 Mar 10;24(6):5340. doi: 10.3390/ijms24065340.

Abstract

It is extremely difficult to achieve functional recovery after axonal injury in the adult central nervous system. The activation of G-protein coupled receptor 110 (GPR110, ADGRF1) has been shown to stimulate neurite extension in developing neurons and after axonal injury in adult mice. Here, we demonstrate that GPR110 activation partially restores visual function impaired by optic nerve injury in adult mice. Intravitreal injection of GPR110 ligands, synaptamide and its stable analogue dimethylsynaptamide (A8) after optic nerve crush significantly reduced axonal degeneration and improved axonal integrity and visual function in wild-type but not gpr110 knockout mice. The retina obtained from the injured mice treated with GPR110 ligands also showed a significant reduction in the crush-induced loss of retinal ganglion cells. Our data suggest that targeting GPR110 may be a viable strategy for functional recovery after optic nerve injury.

Keywords: A8; axonal degeneration; neuronal survival; optic nerve crush; retinal ganglion cells; synaptamide; visual evoked potential.

MeSH terms

  • Animals
  • Axons
  • Ligands
  • Mice
  • Mice, Knockout
  • Nerve Crush
  • Nerve Regeneration / physiology
  • Optic Nerve Injuries*
  • Receptors, G-Protein-Coupled / genetics
  • Retina
  • Retinal Ganglion Cells / physiology

Substances

  • Ligands
  • Receptors, G-Protein-Coupled
  • ADGRF1 protein, mouse